GlaxoSmithKline Plc teams up with GlycoVaxyn
U.K.’s largest drugmaker, GlaxoSmithKline Plc will join hands with GlycoVaxyn AG to develop new anti-bacterial conjugate vaccines, an $8 billion market.
GlycoVaxyn will also get an upfront payment as an equity investment from the drug company, which has an option to get an exclusive license on vaccines they work on during the 3-year collaboration period.
The company is also eligible to get milestone payments and royalties if the vaccines win regulatory nod. The financial terms of the deal were not disclosed.
GlycoVaxyn focuses on vaccines against the common severe bacterial infections. Its most advanced program is the vaccine against the Shigella bacterium, which causes dysentery and blood diarrhea. The pre-clinical candidates include vaccines to prevent hospital infections and E.coli.
Philippe Dro, GlycoVaxyn CEO said, “The collaboration with vaccine industry leader confirms the potential of our platform to generate new complex vaccines.” GlycoVaxyn uses recombinant DNA technology that allows it to target bacterial diseases for which effective vaccines don’t yet exist, according to the company.
Investors in GlycoVaxyn include Sofinnova Partners, Index Ventures and Edmond de Rothschild Investment Partners.
GlaxoSmithKline Plc is a British multinational pharmaceutical, biologics, vaccines and consumer healthcare company based in London. It is the world’s the fourth-largest pharmaceutical company measured by 2009 prescription drug sales.
LG launches purpose-built smart TV for hospitals
LG Business Solutions USA has announced two new hospital TVs that are designed to improve patient management and engagement while adhering to critical safety standards for healthcare facilities.
One of the TVs is LG's biggest ever screen for a hospital - the 65-inch 4K Ultra HD model. It has LG’s NanoCell display technology, enabling it to display vivid pictures, and provides built-in support for hospital pillow speakers and embedded broadband LAN capability, so hospitals can deliver video on demand without requiring a separate set-top box in the patient room.
It also includes configuration software with an intuitive interface for setting up the TV to work in a hospital setting, plus a software-enabled access point feature that turns the TV into a Wi-Fi hotspot.
The second TV screen is the 15-inch Personal Healthcare Smart Touch TV with a multi-touch screen. It is designed to be installed on an adjustable arm for use in shared spaces or smaller patient rooms and will support LG's new, modular LG AM-AC21EA video camera, and HD video communication.
Both include support for video conferencing, and are UL Certified for use in healthcare facilities, a global safety standard. They also feature LG’s integrated Pro:Centric hospital management solutions, allowing hospitals and LG’s patient engagement development partners to personalise a patient's room, providing entertainment, hospital information, services, patient education, and more.
Additionally its communication platform makes it possible to conduct video calls between patients and clinicians or family.
“Our newest LG hospital TVs reflect ongoing feedback from the industry and include capabilities integrated to meet the unique needs of a critical market” said Tom Mottlau, Director of Healthcare Solutions, LG Electronics USA.
“Our healthcare patient engagement development partners requested an upgradable version of webOS for our Pro:Centric smart TV platform so they could more easily introduce new features for their hospital customers. For the latest versions of webOS, LG worked closely with our partners to make their request a reality and to deliver a hospital TV platform that can evolve over time.”